Yong-hong Wang
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Sexual dysfunction in chronic hepatitis B: a comprehensive review of pathophysiology, clinical burden, and integrated management.
Journal: Frontiers in public health
Published: April 26, 2026
Discontinuation of nucleos(t)ide analogues after NA-induced HBsAg seroclearance: a single-center 48-week retrospective study.
Journal: Journal of virus eradication
Published: October 24, 2025
Quantitative Measurement of Serum HBcrAg Can Be Used to Assess the Feasibility of Safe Discontinuation of Antiviral Therapy for Chronic Hepatitis B.
Journal: Viruses
Published: February 02, 2024
Tracking of Stem Cells in Chronic Liver Diseases: Current Trends and Developments.
Journal: Stem cell reviews and reports
Published: November 15, 2023
Improved bone and renal safety in younger tenofovir disoproxil fumarate experienced chronic hepatitis B patients after switching to tenofovir alafenamide or entecavir.
Journal: Annals of hepatology
Published: January 25, 2023
Mesenchymal Stem Cell Therapy in Acute Liver Failure.
Journal: Gut and liver
Published: September 24, 2022
The high level of IL-1β in the serum of ACLF patients induces increased IL-8 expression in hUC-MSCs and reduces the efficacy of hUC-MSCs in liver failure.
Journal: Stem cell research & therapy
Published: July 24, 2022
Upregulation of microRNA-125b-5p alleviates acute liver failure by regulating the Keap1/Nrf2/HO-1 pathway.
Journal: Frontiers in immunology
Published: July 07, 2022
Serum Pregenomic RNA Combined With Hepatitis B Core-Related Antigen Helps Predict the Risk of Virological Relapse After Discontinuation of Nucleos(t)ide Analogs in Patients With Chronic Hepatitis B.
Journal: Frontiers in microbiology
Published: March 21, 2022
Retrospective Analysis of the Clinical Efficacy of N-Acetylcysteine in the Treatment of Hepatitis B Virus Related Acute-on-Chronic Liver Failure.
Journal: Frontiers in medicine
Published: June 12, 2021
Cell heterogeneity, rather than the cell storage solution, affects the behavior of mesenchymal stem cells in vitro and in vivo.
Journal: Stem cell research & therapy
Published: December 03, 2020
Last Updated: 09/26/2026